Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,515.39
    -1,025.63 (-1.99%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Company News For Dec 11, 2018

In 2019, First Solar's (FSLR) module sales are expected to grow significantly to approximately 4 gigawatts.
  • Travelport Worldwide Limited’s TVPT shares jumped 3.1% after the company agreed to be bought by affiliates of Siris Capital Group and Evergreen Coast Capital for about $4.4 billion or $15.75 per share in cash

  • Shares of Aurora Cannabis Inc. ACB declined 0.4% after the company announced it was entering a letter of intent to acquire Farmacias Magistrales SA in a stock deal

  • Linde plc’s LIN shares gained 2.7% after the company announced a $1 billion share repurchase program

  • Shares of Nutrisystem, Inc. NTRI surged 27.7% after the company agreed to be acquired by
    Tivity Health, Inc. TVTY for $1.3 billion in stock and cash


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Travelport Worldwide Limited (TVPT) : Free Stock Analysis Report
 
NutriSystem Inc (NTRI) : Free Stock Analysis Report
 
Healthways, Inc. (TVTY) : Free Stock Analysis Report
 
Praxair, Inc. (LIN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research